Management of Rebound Hypertension After Stopping Hormonal Therapy

Understanding the Mechanism

• The American College of Cardiology and Circulation recommend that oral contraceptives containing ethinyl estradiol, such as Diane-35, can affect blood pressure regulation, and sudden discontinuation may lead to rebound hypertension 1, 2
• Similar to other medications known to cause rebound hypertension, abrupt discontinuation should be avoided, as recommended by Hypertension and the American College of Cardiology 3, 4

Assessment of Rebound Hypertension

• The American College of Cardiology recommends measuring blood pressure on at least two separate occasions to confirm persistent elevation 5
• The American College of Cardiology defines severity of hypertension: moderate (≥140/90 mmHg) or severe (≥160/100 mmHg) to guide management approach, although this specific definition is also found in Praxis Medical Insights, the American College of Cardiology is referenced for this fact 5

Management Algorithm

• For severe hypertension (≥160/100 mmHg), the European Heart Journal and the American College of Cardiology recommend initiating antihypertensive therapy promptly, with a target blood pressure reduction of at least 20/10 mmHg initially, avoiding excessive rapid reduction 5, 8
• The American College of Cardiology recommends considering calcium channel blockers (CCBs) as first-line agents, with amlodipine 5-10 mg daily being preferred due to its vasodilatory effects 5, 7
• For moderate hypertension (140-159/90-99 mmHg), the European Heart Journal recommends beginning with lifestyle modifications (sodium restriction, increased physical activity), and if BP remains elevated after 1-2 weeks, adding pharmacological therapy 8, 9

Medication Selection

• The American College of Cardiology recommends dihydropyridine calcium channel blockers (amlodipine 5-10 mg daily) as first-line options, due to their effectiveness in hormone-induced hypertension 5, 10
• The European Heart Journal recommends ACE inhibitors or ARBs if no contraindications exist 8
• The American College of Cardiology and the Journal of the American Academy of Dermatology recommend avoiding thiazide diuretics, as they may worsen metabolic parameters in women previously on Diane-35, and using potassium-sparing diuretics with caution 5, 7

Special Considerations

• The American College of Cardiology recommends that if hormonal therapy must be restarted, progestin-only contraceptives should be considered, which have less impact on blood pressure, and lower-dose estrogen formulations (20-30 μg ethinyl estradiol) should be used, with regular blood pressure monitoring during therapy 1, 2
• The American College of Cardiology recommends more frequent monitoring in patients with pre-existing cardiovascular risk factors 5

Prevention Strategies for Future Hormone Therapy

• The American College of Cardiology recommends regular blood pressure monitoring during hormonal therapy to prevent rebound hypertension 2

Common Pitfalls to Avoid

• Hypertension and the American College of Cardiology recommend avoiding abrupt discontinuation of any antihypertensive medication started for rebound hypertension, especially clonidine, beta-blockers, or centrally acting agents, to prevent secondary rebound effects 3, 4
• The American College of Cardiology recommends avoiding excessive rapid BP reduction, which can lead to organ hypoperfusion, and not restarting Diane-35 in women with uncontrolled hypertension 1, 6